Analysts Set The Clorox Company (CLX) PT at $129.53

The Clorox Company (NYSE:CLX) has been assigned a consensus recommendation of “Hold” from the fifteen ratings firms that are currently covering the firm, MarketBeat reports. Three research analysts have rated the stock with a sell rating, ten have given a hold rating and two have given a buy rating to the company. The average twelve-month target price among analysts that have issued a report on the stock in the last year is $129.53.

A number of brokerages recently weighed in on CLX. Barclays reiterated a “hold” rating and set a $135.00 price target on shares of The Clorox in a research note on Friday, March 16th. Bank of America decreased their price target on shares of The Clorox from $140.00 to $130.00 and set a “hold” rating for the company in a research note on Thursday, May 3rd. BMO Capital Markets set a $147.00 price target on shares of The Clorox and gave the stock a “buy” rating in a research note on Monday, February 5th. Wells Fargo decreased their price target on shares of The Clorox from $140.00 to $130.00 and set a “market perform” rating for the company in a research note on Thursday, April 19th. Finally, Zacks Investment Research downgraded shares of The Clorox from a “buy” rating to a “hold” rating in a research report on Monday, January 22nd.

Get The Clorox alerts:

Shares of NYSE:CLX opened at $118.38 on Monday. The firm has a market cap of $15.20 billion, a P/E ratio of 22.13, a price-to-earnings-growth ratio of 2.63 and a beta of 0.37. The company has a quick ratio of 0.93, a current ratio of 1.18 and a debt-to-equity ratio of 2.14. The Clorox has a 1-year low of $117.44 and a 1-year high of $118.56.

The Clorox (NYSE:CLX) last issued its quarterly earnings results on Wednesday, May 2nd. The company reported $1.37 earnings per share for the quarter, topping the Zacks’ consensus estimate of $1.31 by $0.06. The firm had revenue of $1.52 billion during the quarter, compared to analysts’ expectations of $1.51 billion. The Clorox had a net margin of 13.27% and a return on equity of 107.93%. The Clorox’s quarterly revenue was up 2.7% compared to the same quarter last year. During the same quarter in the prior year, the business earned $1.31 EPS. research analysts expect that The Clorox will post 5.73 earnings per share for the current fiscal year.

A number of institutional investors have recently made changes to their positions in the business. Jensen Investment Management Inc. increased its holdings in shares of The Clorox by 12.1% in the 4th quarter. Jensen Investment Management Inc. now owns 40,960 shares of the company’s stock valued at $6,092,000 after purchasing an additional 4,435 shares in the last quarter. Spearhead Capital Advisors LLC purchased a new position in shares of The Clorox in the 4th quarter valued at about $2,846,000. Advisor Group Inc. increased its holdings in shares of The Clorox by 26.8% in the 4th quarter. Advisor Group Inc. now owns 48,896 shares of the company’s stock valued at $7,276,000 after purchasing an additional 10,335 shares in the last quarter. Northeast Investment Management increased its holdings in shares of The Clorox by 1.0% in the 4th quarter. Northeast Investment Management now owns 103,054 shares of the company’s stock valued at $15,328,000 after purchasing an additional 1,050 shares in the last quarter. Finally, Victory Capital Management Inc. increased its holdings in shares of The Clorox by 10.7% in the 4th quarter. Victory Capital Management Inc. now owns 25,475 shares of the company’s stock valued at $3,789,000 after purchasing an additional 2,465 shares in the last quarter. Institutional investors own 76.39% of the company’s stock.

The Clorox Company Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Cleaning, Household, Lifestyle, and International. The company offers laundry additives, including bleach products under the Clorox brand, as well as Clorox 2 stain fighters and color boosters; home care products primarily under the Clorox, Formula 409, Liquid-Plumr, Pine-Sol, S.O.S, and Tilex brands; naturally derived products under the Green Works brand; and professional cleaning and disinfecting products under the Clorox, Dispatch, Aplicare, HealthLink, and Clorox Healthcare brands.

Analyst Recommendations for The Clorox (NYSE:CLX)

Leave a Reply

Your email address will not be published. Required fields are marked *